Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Scientific Reports|November 20, 2023
Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling studyAli Mahdi, Allan Zhao, Emelie Fredengren, et al.
Stem Cell Reports|April 13, 2016
Loss of CSL Unlocks a Hypoxic Response and Enhanced Tumor Growth Potential in Breast Cancer CellsEike-Benjamin Braune, Yat Long Tsoi, Yee Peng Phoon, et al.
Nature Biotechnology|July 24, 2012
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsDaniel Ramsköld, Shujun Luo, Yu-Chieh Wang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 6, 2023
Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neuronsSwapnali Barde, Julio Aguila, Wen Zhong, et al.
Nature Biotechnology|February 5, 2020
Author Correction: Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cellsDaniel Ramsköld, Shujun Luo, Yu-Chieh Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2026
Decoding Human Placental Cellular and Molecular Responses to Obesity and Fetal GrowthHong Jiang, Emilie Derisoud, Denise Parreira, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
The discovery of potent antagonists of NPBWR1 (GPR7)F Anthony Romero, Nicholas B Hastings, Remond Moningka, et al.
Molecular Pharmacology|September 28, 2011
Identification of novel and selective Kv2 channel inhibitorsJames Herrington, Kelli Solly, Kevin S Ratliff, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2025
Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degradersXuqing Zhang, Qiaolin Deng, Harshil Dhruv, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2020
Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide coresJian Liu, Patrick P Shao, Deodial Guiadeen, et al.
Pageof 14